As shown in Fig. 6, our research confirms that the activation of circular pathway and continuous activation of NF-κB caused by the decrease of ICL in lung tissue and cells of COPD patients should promote carcinogenesis and tumor progression in COPD patients. This evidence concerns the gene NFKB1 and neoplasm.